Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Vasavda

1079 Phospho-Proteomic Profiling Reveals Distinct Signaling Pathways by First and Third Generation EGFR Inhibitors in Human Keratinocytes: Implications for Adverse Dermatologic Reactions

Journal of Investigative Dermatology

English

Related publications

Management of Egfr Tki–induced Dermatologic Adverse Events

Current Oncology

Oncology

2015

English

Elucidation of Xenobiotic Metabolism Pathways in Human Skin and Human Skin Models by Proteomic Profiling

PLoS ONE

Multidisciplinary

2012

English

Structural Differences Between Wild-Type and Double Mutant EGFR Modulated by Third-Generation Kinase Inhibitors

Journal of the American Chemical Society

English

Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer

Cancer Research

Oncology

2019

English

Generation of Distinct Signaling Modes via Diversification of the Egfr Ligand-Processing Cassette

Development (Cambridge)

Developmental Biology

Molecular Biology

2010

English

Genotyping, Generation and Proteomic Profiling of the First Human Autosomal Dominant Osteopetrosis Type II-specific Induced Pluripotent Stem Cells

Stem Cell Research and Therapy

English

WZ4002, a Third-Generation EGFR Inhibitor, Can Overcome Anoikis Resistance in EGFR-mutant Lung Adenocarcinomas More Efficiently Than SRC Inhibitors

Laboratory Investigation

English

Dermatologic Events From EGFR Inhibitors: The Issue of the Missing Patient Voice

Supportive Care in Cancer

Oncology

2016

English

886 Proteomic and Phosphoproteomic Analysis Reveals Distinct Signatures and Regulatory Signaling in Quiescent and Primed Hair Follicle Stem Cells

Journal of Investigative Dermatology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Vasavda

1079 Phospho-Proteomic Profiling Reveals Distinct Signaling Pathways by First and Third Generation EGFR Inhibitors in Human Keratinocytes: Implications for Adverse Dermatologic Reactions

Related publications

Management of Egfr Tki–induced Dermatologic Adverse Events

Elucidation of Xenobiotic Metabolism Pathways in Human Skin and Human Skin Models by Proteomic Profiling

Structural Differences Between Wild-Type and Double Mutant EGFR Modulated by Third-Generation Kinase Inhibitors

Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer

Generation of Distinct Signaling Modes via Diversification of the Egfr Ligand-Processing Cassette

Genotyping, Generation and Proteomic Profiling of the First Human Autosomal Dominant Osteopetrosis Type II-specific Induced Pluripotent Stem Cells

WZ4002, a Third-Generation EGFR Inhibitor, Can Overcome Anoikis Resistance in EGFR-mutant Lung Adenocarcinomas More Efficiently Than SRC Inhibitors

Dermatologic Events From EGFR Inhibitors: The Issue of the Missing Patient Voice

886 Proteomic and Phosphoproteomic Analysis Reveals Distinct Signatures and Regulatory Signaling in Quiescent and Primed Hair Follicle Stem Cells